Paradoxically increased FOXP3+ T cells in IBD do not preferentially express the isoform of FOXP3 lacking exon 2.

Paradoxically increased FOXP3+ T cells in IBD do not preferentially express the isoform of FOXP3 lacking exon 2.
复制标题

DOI:
10.1007/s10620-012-2292-3
复制
发表时间:
2012-11
影响因子:
3.1
通讯作者:
Ziegler, Steven F.
Ziegler, Steven F.
中科院分区:
医学3区
文献类型:
--
作者:
Lord, James D.;Valliant-Saunders, Karine;Hahn, Hejin;Thirlby, Richard C.;Ziegler, Steven F.

文献摘要

参考文献

被引文献

相似文献

FOXP3+ regulatory T cells (Tregs) are critical for controlling inflammation in the gastrointestinal (GI) tract. There is a paradoxical increase of mucosal FOXP3+ T cells in patients with inflammatory bowel disease (IBD). These FOXP3+ cells were recently shown to include IL-17A-producing cells in Crohn’s disease, resembling Th17 cells implicated in autoimmune diseases. FOXP3 inhibits IL-17A production, but a naturally-occurring splice variant of FOXP3 lacking exon 2 (Δexon2) cannot. We hypothesized that IBD patients preferentially express the Δexon2 variant of FOXP3 so the paradoxically increased mucosal Tregs in IBD could represent cells expressing only Δexon2. We used antibodies and primers that can distinguish between the full-length and Δexon2 splice variant of FOXP3 to evaluate expression of these isoforms in human intestinal tissue by immunohistochemistry (IHC) and quantitative PCR, respectively. No difference in the expression pattern of Δexon2 relative to full length FOXP3 was seen in ulcerative colitis (UC) or Crohn’s disease versus non-IBD controls. By immunofluorescence microscopy and flow cytometry, we also did not find individual cells which expressed FOXP3 protein exclusively in the Δexon2 isoform in either IBD or control tissue. FOXP3+ mucosal CD4+ T cells from both IBD and control specimens were able to make IL-17A in vitro after PMA and ionomycin stimulation, but these cells did not preferentially express Δexon2. Our data do not support the hypothesis that selective expression of FOXP3 in the Δexon2 isoform accounts for the inability of copious FOXP3+ T cells to inhibit inflammation or IL-17 expression in IBD.
DOI: 10.1016/j.cell.2006.07.035
发表时间: 2006-09-22
期刊: CELL
影响因子: 64.5
作者:
Ivanov, Ivaylo I.;McKenzie, Brent S.;Littman, Dan R.
通讯作者: Littman, Dan R.
DOI: 10.1084/jem.20070663
发表时间: 2007-08-06
期刊: The Journal of experimental medicine
影响因子: --
作者:
Annunziato F;Cosmi L;Santarlasci V;Maggi L;Liotta F;Mazzinghi B;Parente E;Filì L;Ferri S;Frosali F;Giudici F;Romagnani P;Parronchi P;Tonelli F;Maggi E;Romagnani S
通讯作者: Romagnani S
DOI: 10.1038/nature04753
发表时间: 2006-05-11
期刊: NATURE
影响因子: 64.8
作者:
Bettelli, E;Carrier, YJ;Kuchroo, VK
通讯作者: Kuchroo, VK
DOI: 10.1371/journal.pone.0006104
发表时间: 2009-07-01
期刊: PloS one
影响因子: 3.7
作者:
Mailer RK;Falk K;Rötzschke O
通讯作者: Rötzschke O
DOI: 10.1038/ng.717
发表时间: 2010-12
期刊: Nature genetics
影响因子: 30.8
作者:
通讯作者: --